Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Chemical and Drug Induced Liver Injury × Ursodeoxycholic Acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 2 Colorectal Neoplasms 2 Hepatitis 1 Colonic Neoplasms 1 Chemical and Drug Induced Liver Injury 1

Interventions

Ursodeoxycholic Acid 1 Surgical Procedures, Operative 1 Steroids 1 S-Adenosylmethionine 1 Prednisone 1 Mycophenolic Acid 1 Methylprednisolone Hemisuccinate 1 Methylprednisolone 1 Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04810156 2022-12-14

I-HEP

Herlev Hospital

Phase 2 Unknown

Hepatitis, Neoplasms, Chemical and Drug Induced Liver Injury

Data powered by HemOnc (CC BY 4.0) Colophon ⚡